admin

Biotechnology is the source of some of our strongest and growing revolutions. Gene technology allows us to cure incurable diseases and make miracles happen with living organisms. Immunotherapies promise targeted treatment without harmful side effects. And more and more, we are understanding the deep structure of cancers, allowing us to develop treatments that promise a
0 Comments
Although we’re far removed from the financial sector crisis, many investors understandably feel shaky about bank stocks to buy. According to a CNN report at the end of May this year, the lingering effects of the calamity have not been fully extinguished. It’s just that we’re distracted with other concerns, meaning we could see another
0 Comments
With the innovation sector moving at full speed, it’s time for investors to consider the best tech stocks to buy now but not necessarily for the reason you might assume. Yes, the exchange-traded fund Technology Select Sector SPDR Fund (NYSEARCA:XLK) has easily outperformed the benchmark SPDR S&P 500 ETF Trust (NYSEARCA:SPY) over the past five
0 Comments
While energy stocks as a broader market segment have been rather inconsistent this year, over the long run, demand should turn decisively in the positive direction. It really comes down to simple math. Fundamentally, while many developed nations incur slowing population growth, on a nominal basis, the U.S. will still absorb a significant number of
0 Comments
Navigating the ever-evolving investment landscape can be a daunting task, especially with buzzwords like “Web3 stocks” making headlines. These stocks represent the next frontier in the digital realm, leveraging the power of decentralized platforms to reshape industries and consumer experiences. In this new era, opportunities abound, but so do risks. On one hand, there’s undeniable
0 Comments
Without a doubt, electric vehicle charging station manufacturer ChargePoint (NYSE:CHPT) has disappointed many investors in 2023. CHPT stock has been a poor performer this year, and prudent traders should cut their losses and move on. If you’re not convinced of this, wait until you get the details of ChargePoint’s recent capital-raising efforts. Sure, ChargePoint’s management might
0 Comments
The recent strikes by Kaiser Permanente workers speak to greater structural issues that threaten weaker healthcare stocks in general. It’s clear that healthcare firms are increasingly under greater pressure to improve working conditions. That pressure magnifies issues for firms overall. Such firms can either acquiesce to union demands or face a heightened risk of further
0 Comments
Defense stocks are back in the spotlight amid rising global geopolitical tensions. The war in Russia and Ukraine was a testament to the rapidly evolving economic and political instability. Even as the economy faces many challenges, global aerospace and defense spending will continue to rise YOY. Several conflicts have emerged, including the recent Israel-Hamas war, leading
0 Comments
I’ve taken a generally bearish stance on Palantir Technologies (NYSE:PLTR) for quite some time now. That’s generally due to various fundamental concerns I have with the company, as well as questionable forward growth expectations.  However, putting all that aside, I thought I’d take a look at the bull case for Palantir. Let’s dive into the company’s
0 Comments